Target intelligence / Profile preview

Energy metabolism pathways in myocardium

Molecular classification
Other (Pathway/network; contains enzymes, transporters, and regulators, but is not itself a molecule or family)
01

Overview

Energy metabolism pathways in the myocardium are an interconnected set of biochemical processes that enable the heart to generate ATP to support contractile function. Major pathways include glycolysis, glucose oxidation, fatty acid oxidation, and ketone body oxidation. Substrate selection and metabolic flux are dynamically regulated to match cardiac energy demand. Dysfunction in these pathways is associated with heart failure, cardiomyopathy, diabetes, and other cardiac diseases. While individual enzymes and transporters within these pathways (e.g., pyruvate dehydrogenase, carnitine palmitoyltransferase, glucose transporters) are valid drug targets, the collective pathway itself is not a canonical molecule, receptor, or single therapeutic target[1][3][4][5].

Other names
Myocardial energy metabolismCardiac energy metabolism pathwaysCardiac metabolic networks
02

Mechanism of action

Drugs modulate specific enzymes or transporter activity within the myocardium, shifting substrate preference (e.g., from fatty acid to glucose oxidation) or increasing efficiency of ATP production

03

Biological functions

Energy productionRegulation of substrate utilizationATP synthesis for contractile function
04

Disease associations

Cardiovascular disease (including heart failure, diabetic cardiomyopathy, ischemic heart disease, Chagas cardiomyopathy)Other (metabolic syndrome, cardiac aging, inherited metabolic disorders)
05

Safety considerations

Off-target metabolic effectsHypoglycemia (when shifting metabolism towards glucose utilization)Altered lipid metabolism with risk of lipotoxicityMitochondrial toxicity
06

Interacting drugs

Trimetazidine

3 more in the full profile.

07

Biomarkers

Circulating ketone bodiesMyocardial acetyl-CoA/CoA ratioEnzyme levels (e.g., ACADVL, BDH1, SCOT)Malonaldehyde (for oxidative stress in metabolic dysfunction)

Beyond the preview

Go deeper on Energy metabolism pathways in myocardium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Energy metabolism pathways in myocardium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call